Ozempic , containing the active ingredient semaglutide GLP-1 , is primarily prescribed for managing type 2 diabetes
Tesamorelin improves body composition through growth hormone pathways that also support bone density, skin quality, and recovery capacity
Cycle properly
Semaglutide is used in conjunction with diet and exercise to support healthy weight , receiving approval from the Food and Drug Administration as a weight loss treatment in 2021
Archived from the original on May 25, 2009
Affordability and access While clinical innovation is expanding the potential GLP-1 patient base, with approvals over the last year also in cardiovascular and kidney disease and sleep apnea, the question of access remains deeply unresolved, especially in the US market